XML 11 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2026
Mar. 31, 2026
Current assets:    
Cash and cash equivalents $ 3,058 $ 2,751
Short-term investments 830 850
Accounts receivable, net (including receivables from related parties of $281 and $270 as of June 30, 2026 and March 31, 2026, respectively) 1,119 1,300
Contract assets (including contract assets from related parties of $577 and $646 as of June 30, 2026 and March 31, 2026, respectively) 881 977
Prepaid expenses and other current assets 451 358
Total current assets 6,339 6,236
Non-current assets:    
Property and equipment, net 923 772
Operating lease right-of-use assets 406 379
Finance lease right-of-use assets 62 69
Equity investments (including investments held under fair value option of $141 and $148 as of June 30, 2026 and March 31, 2026, respectively) 589 387
Goodwill 1,623 1,623
Intangible assets, net 217 230
Deferred tax assets 425 375
Non-current portion of contract assets 366 320
Other non-current assets 246 312
Total non-current assets 4,857 4,467
Total assets 11,196 10,703
Current liabilities:    
Accrued compensation and benefits 156 154
Tax liabilities 114 106
Contract liabilities (including contract liabilities from related parties of $29 and $36 as of June 30, 2026 and March 31, 2026, respectively) 200 294
Operating lease liabilities 41 39
Other current liabilities (including payables to related parties of $30 and $20 as of June 30, 2026 and March 31, 2026, respectively) 696 447
Total current liabilities 1,207 1,040
Non-current liabilities:    
Non-current portion of accrued compensation 33 32
Deferred tax liabilities 23 39
Non-current portion of contract liabilities (including non-current portion of contract liabilities from related parties of 739 752
Non-current portion of operating lease liabilities 423 393
Other non-current liabilities 141 161
Total non-current liabilities 1,359 1,377
Total liabilities 2,566 2,417
Commitments and contingencies (Note 13)
Shareholders’ equity:    
Ordinary shares, $0.001 par value; 1,111 shares authorized and 1,068 shares issued and outstanding as of June 30, 2026; and 1,097 shares authorized and 1,064 shares issued and outstanding as of March 31, 2026 2 2
Additional paid-in capital 3,538 3,467
Accumulated other comprehensive income (loss) 373 370
Retained earnings 4,717 4,447
Total shareholders’ equity 8,630 8,286
Total liabilities and shareholders’ equity $ 11,196 $ 10,703